Header Logo

Connection

BIYKEM BOZKURT to Tetrazoles

Back to Details
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Tetrazoles.
BIYKEM BOZKURT
Connection Strength
0.765
Tetrazoles
  1. Ten years real-world experience with sacubitril/valsartan in patients with heart failure with reduced ejection fraction. ESC Heart Fail. 2026 Mar 03; 13(2).
    View in: PubMed
    Score: 0.231
  2. Heart?Failure Drug Treatment-Inertia,?Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF). JACC Heart Fail. 2023 01; 11(1):1-14.
    View in: PubMed
    Score: 0.182
  3. Ins and Outs: Perspectives of Inpatient Prescribing for Sacubitril/Valsartan. Ann Pharmacother. 2021 06; 55(6):805-813.
    View in: PubMed
    Score: 0.160
  4. Substance and Substrate: LVEF and Sex Subgroup Analyses of PARAGON-HF and PARADIGM-HF Trials. Circulation. 2020 02 04; 141(5):362-366.
    View in: PubMed
    Score: 0.152
  5. Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure. Circulation. 2001 Feb 20; 103(7):973-80.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.